Published in J Clin Invest on July 01, 1993
Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest (1995) 1.60
Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A (1996) 1.51
Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest (1996) 1.03
The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci U S A (1995) 0.96
Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells. Clin Exp Immunol (1998) 0.86
Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase. Clin Exp Immunol (1995) 0.84
Molecular biology of IDDM. Diabetologia (1994) 0.77
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Homologous plant and bacterial proteins chaperone oligomeric protein assembly. Nature (1988) 9.55
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71
Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet (1990) 3.46
Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem (1988) 2.78
Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem (1991) 2.66
Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1990) 2.23
Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest (1987) 2.09
Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci U S A (1991) 1.74
64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet (1990) 1.70
Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.67
Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble. J Biol Chem (1991) 1.54
Association between the mammalian 110,000-dalton heat-shock protein and nucleoli. J Cell Biol (1983) 1.40
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience (1981) 1.40
Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med (1990) 1.36
Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia (1988) 1.32
Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes (1989) 1.30
Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes (1992) 1.20
Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Diabetes (1992) 1.10
Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1991) 1.10
Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes (1990) 1.03
Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia (1992) 1.03
Cellular and subcellular localization of an Mr 64,000 protein autoantigen in insulin-dependent diabetes. J Biol Chem (1990) 0.99
Alternative self or nonself recognition of an antigen expressed in a rare cell type in transgenic mice: implications for self-tolerance and autoimmunity. Cold Spring Harb Symp Quant Biol (1989) 0.88
No evidence for serological autoimmunity to islet cell heat shock proteins in insulin dependent diabetes. J Clin Invest (1991) 0.85
Secretory granule autoantigen in insulin-dependent diabetes mellitus is related to 62 kDa heat-shock protein (hsp60). J Autoimmun (1992) 0.81
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess (2004) 3.73
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med (1997) 3.31
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab (2001) 3.09
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med (1996) 2.94
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med (1993) 2.47
The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev (2008) 2.39
Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev (2005) 2.17
Genetic and functional analysis of the Ia antigens: their possible role in regulating the immune response. Transplant Rev (1976) 2.15
Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care (2000) 2.14
Effect of disinfectants on pathogenic free-living amoebae: in axenic conditions. Appl Environ Microbiol (1980) 2.08
Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-CW3). EMBO J (1984) 1.92
Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array. J Clin Microbiol (2000) 1.88
Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci (1997) 1.84
Use of cell cultures as an indicator of pathogenicity of free-living amoebae. J Clin Pathol (1978) 1.72
Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol (1997) 1.62
Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. Proc Natl Acad Sci U S A (1994) 1.56
Long latency pneumonia: a case of melioidosis. J Infect (1990) 1.54
Antigen-induced Ca2+ signaling and desensitization in B cells. J Immunol (1990) 1.50
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol (1997) 1.48
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes (1994) 1.48
Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. J Immunol (1991) 1.45
Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob Agents Chemother (2005) 1.45
Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res (1993) 1.44
Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess (2006) 1.41
Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol (1992) 1.40
Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med (1990) 1.36
Immunity to pathogenic free-living amoebae: role of humoral antibody. Infect Immun (1980) 1.31
Virulence of pathogenic free-living amebae. J Parasitol (1978) 1.29
Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta. Br J Pharmacol (1991) 1.29
In vitro analysis of allogeneic lymphocyte interaction. I. Characterization and cellular origin of an Ia-positive helper factor-allogeneic effect factor. J Exp Med (1977) 1.26
p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J Immunol (1999) 1.25
What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet (2004) 1.23
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol (2001) 1.23
Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A (1992) 1.23
cDNAs encoding the beta subunit of cap Z, the actin-capping protein of the Z line of muscle. J Biol Chem (1989) 1.20
Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes (1992) 1.20
Amoebae from antarctic soil and water. Appl Environ Microbiol (1982) 1.19
Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes (1994) 1.19
TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J Immunol (1999) 1.18
Motion analysis. Surg Endosc (2001) 1.17
Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine. Clin Microbiol Infect (2007) 1.17
Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol (2000) 1.16
Estimation of light-chain gene reiteration of mouse immunoglobulin by DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 1.16
Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med (1993) 1.15
Metabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs. Drug Metab Dispos (1993) 1.15
MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells. Br J Cancer (2007) 1.14
Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J Immunol (1993) 1.14
Isolation and characterization of cDNA encoding the alpha subunit of Cap Z(36/32), an actin-capping protein from the Z line of skeletal muscle. Proc Natl Acad Sci U S A (1989) 1.14
Regulation of inflammatory responses by oncostatin M. J Immunol (1999) 1.13
Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J Immunol (2001) 1.12
Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Diabetes (1992) 1.10
Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes (1991) 1.09
Effect of the membrane lipid environment on the properties of insulin receptors. Diabetes (1981) 1.09
Viability of pathogenic and nonpathogenic free-living amoebae in long-term storage at a range of temperatures. Appl Environ Microbiol (1984) 1.09
Pathogenic free-living amebae (PFLA) from frozen swimming areas in Oslo, Norway. Scand J Infect Dis (1977) 1.06
What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions. J Hum Nutr Diet (2004) 1.06
Isolation of polysomes from mouse plasmacytomas. Nature (1969) 1.05
Class I histocompatibility antigens and insulin receptors: evidence for interactions. Proc Natl Acad Sci U S A (1986) 1.05
Photoaffinity labeling demonstrates binding between Ia molecules and nominal antigen on antigen-presenting cells. Proc Natl Acad Sci U S A (1986) 1.04
Primary amoebic meningo-encephalitis in an indoor heat-exchange swimming pool. N Z Med J (1979) 1.03
Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes (1990) 1.03
Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med (2000) 1.03
Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia (1992) 1.03
Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem (2001) 1.03
Perineural invasion of cutaneous malignancies. Dermatol Surg (2001) 1.03
Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Cancer Res (2000) 1.02
The identification of actin as a major lymphocyte component. J Immunol (1979) 1.01
Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. J Immunol (1987) 1.00
Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62yes tyrosine kinase. J Immunol (1992) 1.00
Complete spontaneous regression of Merkel cell carcinoma: a review of the 10 reported cases. Dermatol Surg (2000) 0.99
In vitro analysis of allogeneic lymphocyte interaction. II. I-region control of the activity of a B-cell-derived H-2-restricted allogeneic effect factor and its receptor during B-cell activation. J Exp Med (1978) 0.98
Immunity to pathogenic free-living amoebae: role of cell-mediated immunity. Infect Immun (1980) 0.97
Antigen-induced B lymphocyte activation involves the p21ras and ras.GAP signaling pathway. J Exp Med (1993) 0.97
RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine. J Pharmacol Exp Ther (1991) 0.96
Immunochemical evidence for three Ia loci in the I-region of the H-2 complex. J Exp Med (1977) 0.96
Evidence for two homologous, but nonidentical, Ia molecules determined by the I-EC subregion. J Exp Med (1979) 0.96
Immature transformed rat islet beta-cells differentially express C-peptides derived from the genes coding for insulin I and II as well as a transfected human insulin gene. Mol Endocrinol (1992) 0.95
T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease. Immunol Today (1998) 0.94
Expression of murine Ia antigens during embryonic development. J Immunol (1978) 0.94
Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat (2001) 0.94
T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol (1988) 0.94
Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. Implications for the control of expression and immunogenicity of HLA-C antigens. J Immunol (1989) 0.94
Dilute estradiol implants and progestin receptor induction in the ventromedial nucleus of the hypothalamus: correlation with receptive behavior in female rats. Endocrinology (1989) 0.93
Sex differences in the development of estrogen receptors in the rat brain. Horm Behav (1994) 0.93
IgA and primary amoebic meningoencephalitis. Lancet (1979) 0.92
Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts. J Immunol (1996) 0.92
Distribution of occupied and unoccupied estrogen receptors in the rat brain: effects of physiological gonadal steroid exposure. Endocrinology (1995) 0.92
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J Clin Invest (1997) 0.91
Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology (1992) 0.91
Derivation of a monoclonal antibody that detects an Ia antigen encoded by 2 complementing I-subregions. J Immunol (1980) 0.91
Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer. Gene Ther (2000) 0.91
Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int (2007) 0.90
DNA array technology and diagnostic microbiology. Expert Rev Mol Diagn (2001) 0.90
New Glucocorticosteroids with an improved therapeutic ratio? Pulm Pharmacol Ther (2001) 0.90
A new disorder of hyaluronan metabolism associated with generalized folding and thickening of the skin. J Pediatr (2000) 0.89